Targeting DNA Repair Pathways in Prostate Cancer EAU 2026Sent on 16 March 2026
Data Shaping Care in Renal and Upper Tract Cancers from EAU 2026Sent on 16 March 2026
EAU 2026 PSMA-Guided Therapy and New Intensification Strategies in Prostate CancerSent on 15 March 2026
EAU 2026 Where Bladder Cancer Treatment Is Heading NextSent on 15 March 2026
EAU 2026: Surgery and Intravesical Therapy in NMIBCSent on 14 March 2026
EAU 2026: Bladder Sparing Treatment in Non-Muscle Invasive Bladder CancerSent on 14 March 2026
2026 European Association of Urology (EAU) Annual Meeting: Management of Oligometastatic Prostate Cancer: Not as Easy as It SeemsSent on 13 March 2026
Controversies in Onco-Urology, Game Changing Session Highlights, and More From the European Association of Urology (EAU) Annual MeetingSent on 05 July 2022
Clinical Trial Protocol for LuTectomy and Improvements in Metastatic Prostate Cancer: Focus on Imaging and Treatment - The European Association of Urology (EAU) Annual MeetingSent on 04 July 2022
Game Changing Session - Overall Survival with Darolutamide in the ARASENS Trial and Improvements in Metastatic Prostate Cancer: Focus on Imaging and TreatmentSent on 04 July 2022
Joint Session Highlights of the EAU, EANM, ESMO and ESTRO: Modern Diagnostic and Therapeutic Approaches in Prostate Cancer and More from the European Association of Urology (EAU) Annual MeetingSent on 03 July 2022
Perioperative Treatment of Urothelial Cancer and New Insights in the Management of Upper Tract Urothelial Cancer - Highlights from the 2022 European Association of Urology (EAU) Annual MeetingSent on 02 July 2022
Join UroToday for The EAU 2022 Highlights - What to ExpectSent on 28 June 2022
Impact of Decipher Biopsy Testing on Clinical Outcomes in Localized Prostate Cancer in a Prospective Statewide Collaborative Sent on 12 November 2021
Kidney Cancer Association’s International Kidney Cancer Symposium 2021 Meeting Highlights Sent on 07 November 2021
Pivotal Trials Changing the Standard of Care in the Treatment of Advanced GU MalignanciesSent on 13 August 2021
PSMA PET Imaging in Prostate Cancer, Recapping Highlights from the EAU 2021 MeetingSent on 01 August 2021
Treatment Considerations for GU Malignancies Highlights from the EAU 2021 Annual Meeting Sent on 16 July 2021
Treatment of Metastatic Bladder Cancer in 2021 and Kidney Cancer Highlights EAU 2021Sent on 14 July 2021
Advancements in PSMA-PET Imaging and Metastatic Hormone-Sensitive Prostate Cancer Treatments, EAU 2021Sent on 13 July 2021
Controversies in Bladder Cancer 2021 Highlights from the EAU 2021Sent on 12 July 2021
Highlights in Prostate Cancer Screening and Active Surveillance for Intermediate Risk Prostate Cancer - EAU 2021Sent on 11 July 2021
Breakthroughs in the Management of Non-Muscle and Muscle Invasive Bladder Cancer and the Management of Upper Tract Urothelial Cancer - EAU 2021 Sent on 10 July 2021
Radiographic Progression-Free Survival in the PEACE-1 Phase 3 Trial and Prostate Cancer Highlights from the European Association of Urology Annual Congress 2021 Sent on 09 July 2021
Display #
Results 1 - 24 out of 24